[go: up one dir, main page]

FI953302L - Uudet peptidit - Google Patents

Uudet peptidit Download PDF

Info

Publication number
FI953302L
FI953302L FI953302A FI953302A FI953302L FI 953302 L FI953302 L FI 953302L FI 953302 A FI953302 A FI 953302A FI 953302 A FI953302 A FI 953302A FI 953302 L FI953302 L FI 953302L
Authority
FI
Finland
Prior art keywords
new peptides
peptides
new
Prior art date
Application number
FI953302A
Other languages
English (en)
Swedish (sv)
Other versions
FI953302A7 (fi
FI953302A0 (fi
Inventor
Peter Schiller
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI953302L publication Critical patent/FI953302L/fi
Publication of FI953302A7 publication Critical patent/FI953302A7/fi
Publication of FI953302A0 publication Critical patent/FI953302A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI953302A 1993-01-05 1993-12-20 Uudet peptidit FI953302A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300012A SE9300012D0 (sv) 1993-01-05 1993-01-05 New peptides
PCT/SE1993/001090 WO1994015959A1 (en) 1993-01-05 1993-12-20 New peptides

Publications (3)

Publication Number Publication Date
FI953302L true FI953302L (fi) 1995-07-04
FI953302A7 FI953302A7 (fi) 1995-07-04
FI953302A0 FI953302A0 (fi) 1995-07-04

Family

ID=20388466

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953302A FI953302A0 (fi) 1993-01-05 1993-12-20 Uudet peptidit

Country Status (25)

Country Link
US (1) US5602099A (fi)
EP (1) EP0678099A1 (fi)
JP (1) JPH08505386A (fi)
KR (1) KR960700269A (fi)
CN (1) CN1096515A (fi)
AP (1) AP508A (fi)
AU (1) AU681372B2 (fi)
CA (1) CA2152380A1 (fi)
CZ (1) CZ171195A3 (fi)
EE (1) EE9400326A (fi)
FI (1) FI953302A0 (fi)
HU (1) HUT72597A (fi)
IL (1) IL108169A0 (fi)
IS (1) IS4115A (fi)
LV (1) LV10962B (fi)
MX (1) MX9400255A (fi)
NO (1) NO952650L (fi)
NZ (1) NZ259597A (fi)
PL (1) PL309778A1 (fi)
SE (1) SE9300012D0 (fi)
SI (1) SI9400005A (fi)
SK (1) SK83995A3 (fi)
WO (1) WO1994015959A1 (fi)
YU (1) YU394A (fi)
ZA (1) ZA9455B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683121B2 (en) * 1993-12-23 1997-10-30 Novo Nordisk A/S Compounds with growth hormone releasing properties
IS4261A (is) * 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
SE9503924D0 (sv) * 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
IL114046A0 (en) * 1994-06-20 1995-10-31 Astra Ab New opioid peptide antagonists
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
SE9402880D0 (sv) * 1994-08-30 1994-08-30 Astra Ab New peptide derivatives
US5780589A (en) * 1994-11-30 1998-07-14 The United States Of America As Represented By The Department Of Health And Human Services Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU708620B2 (en) * 1995-03-29 1999-08-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0837857A4 (en) * 1995-03-29 1998-08-05 Merck & Co Inc Inhibitors of farnesyl-protein transferase
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
SE9600769D0 (sv) * 1996-02-28 1996-02-28 Astra Ab Compounds useful as analgesic
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
EP1001764A4 (en) * 1997-05-29 2005-08-24 Merck & Co Inc HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
US6703381B1 (en) 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
US6306576B1 (en) * 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US7601739B2 (en) 2003-08-08 2009-10-13 Virgina Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
AU2005286733B2 (en) * 2004-09-23 2009-11-05 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
EP3160497A4 (en) * 2014-06-27 2018-01-17 H. Lee Moffitt Cancer Center And Research Institute, Inc. Conjugates for immunotherapy

Also Published As

Publication number Publication date
US5602099A (en) 1997-02-11
JPH08505386A (ja) 1996-06-11
NZ259597A (en) 1996-07-26
WO1994015959A1 (en) 1994-07-21
CZ171195A3 (en) 1996-09-11
IL108169A0 (en) 1994-04-12
LV10962A (lv) 1995-12-20
HU9502041D0 (en) 1995-09-28
AU5844894A (en) 1994-08-15
PL309778A1 (en) 1995-11-13
HUT72597A (en) 1996-05-28
SI9400005A (en) 1994-12-31
NO952650D0 (no) 1995-07-04
FI953302A7 (fi) 1995-07-04
AU681372B2 (en) 1997-08-28
NO952650L (no) 1995-08-30
KR960700269A (ko) 1996-01-19
YU394A (sh) 1997-07-31
FI953302A0 (fi) 1995-07-04
EE9400326A (et) 1996-04-15
AP9400605A0 (en) 1994-01-31
MX9400255A (es) 1994-07-29
EP0678099A1 (en) 1995-10-25
SE9300012D0 (sv) 1993-01-05
CN1096515A (zh) 1994-12-21
AP508A (en) 1996-07-22
SK83995A3 (en) 1996-09-04
IS4115A (is) 1994-07-06
CA2152380A1 (en) 1994-07-21
ZA9455B (en) 1994-07-05
LV10962B (en) 1997-04-20

Similar Documents

Publication Publication Date Title
FI965225A7 (fi) Uusia peptidejä
FI943084A7 (fi) Uusia sulfonyyliaminopyrimidiinejä
FI961350L (fi) Hapteenimerkityt peptidit
FI953302L (fi) Uudet peptidit
FI954326A0 (fi) Varjoaineisiin liittyviä parannuksia
FI940109A0 (fi) Peptidejä
ATA146094A (de) Windsichter
FI970168A0 (fi) Peptidejä
FI964363L (fi) Peptidejä
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
ATA179094A (de) Kettenschloss
ATA194593A (de) Sportschuh
ATA212793A (de) Sportschuh
ITRC930003A0 (it) Ecomat c
KR940025119U (ko) 관체결구
ATE144907T1 (de) Rollbrett
SE9300722D0 (sv) Novel polypeptides ii
BR9301133A (pt) Hot-ching
BR9301014A (pt) Ofendícula
BR9300030A (pt) Moto-hobby
BR7302251U (pt) Embalagem-produto-inviolável
BR7302123U (pt) Micro-veículos
BR7301713U (pt) Cadeira-escada
BR7301596U (pt) Novaloteca
BR7301580U (pt) Teclimp